Analystreport

Regulus Therapeutics Inc (NASDAQ: RGLS) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.

Regulus Therapeutics Inc.  (RGLS) 
Last regulus therapeutics inc. earnings: 3/12 04:37 pm Check Earnings Report
US:NASDAQ Investor Relations: regulusrx.com/investors